[Rapporto di ricerca] Si prevede che il mercato della neuropatia periferica indotta dalla chemioterapia raggiungerà 1.174,26 milioni di dollari entro il 2028, rispetto agli 813,48 milioni di dollari del 2021; si prevede che registrerà un CAGR del 5,4% dal 2021 al 2028.
La neuropatia periferica indotta dalla chemioterapia è uno degli effetti collaterali più frequenti causati dagli agenti antineoplastici. Clinicamente, è una neuropatia prevalentemente sensoriale che può essere accompagnata da alterazioni motorie e autonomiche di varia intensità e durata. A causa della sua elevata prevalenza tra i pazienti oncologici, la neuropatia periferica indotta dalla chemioterapia costituisce un problema importante sia per i pazienti oncologici e i sopravvissuti, sia per i loro operatori sanitari, soprattutto perché, al momento, non esiste un singolo metodo efficace per prevenirla; inoltre, le possibilità di trattamento di questa sindrome sono limitate.
Personalizza questo report in base alle tue esigenze
Riceverai la personalizzazione gratuita di qualsiasi report, comprese parti di questo report, o analisi a livello nazionale, pacchetto dati Excel, oltre a usufruire di grandi offerte e sconti per start-up e università
Mercato della neuropatia periferica indotta dalla chemioterapia: approfondimenti strategici
- Scopri le principali tendenze di mercato in questo rapporto.Questo campione GRATUITO includerà analisi di dati che spaziano dalle tendenze di mercato alle stime e alle previsioni.
Il rapporto offre approfondimenti e analisi approfondite del mercato della neuropatia periferica indotta da chemioterapia (CIPN), sottolineando le tendenze di mercato, i progressi tecnologici e le dinamiche di mercato. Fornisce inoltre l'analisi del panorama competitivo dei principali attori del mercato in tutto il mondo. Inoltre, il rapporto include l'impatto della pandemia di COVID-19 sul mercato della neuropatia periferica indotta da chemioterapia in tutte le regioni. La pandemia ha creato sia una crisi di salute pubblica che una crisi economica in tutto il mondo. Il mercato globale della neuropatia periferica indotta da chemioterapia prima della pandemia era in costante crescita a causa della regolarità dello screening del cancro, delle consultazioni e dei trattamenti. La prima ondata di COVID-19 ha interrotto le consultazioni, i follow-up e gli screening dei casi oncologici. Inoltre, le interruzioni negli studi clinici e nella fornitura di farmaci ai pazienti durante la fase iniziale della pandemia di COVID-19 hanno avuto un impatto sulle aree più cruciali del mercato della neuropatia periferica indotta da chemioterapia. Uno spostamento dell'attenzione verso il trattamento tempestivo del COVID-19 ha portato a negligenza verso varie altre condizioni mediche. Inoltre, la diminuzione dei casi di cancro rilevati e delle sedute di chemioterapia per il trattamento ha ostacolato la domanda di diagnosi e trattamenti per la neuropatia periferica indotta dalla chemioterapia. neuropathy (CIPN) market emphasizing market trends, technological advancements, and market dynamics. It also provides the competitive landscape analysis of leading market players across the world. Furthermore, the report includes the impact of the COVID-19 pandemic on the neuropathy marketneuropathy before the pandemic was constantly growing owing to regularity of cancer screening, consultations, and treatments. The first wave of COVID-19 disrupted the consultations, follow-ups, and screenings of oncological cases. Moreover, disruptions in clinical trials and drug supply to patients during the early stage of the COVID-19 pandemic impacted the most crucial areas of the chemotherapy induced peripheral neuropathy market. A shift in focus to the prompt treatment of COVID-19 led to negligence toward various other medical conditions. In addition, the decrease in the detection of cancer cases and chemotherapy sessions for treatment hampered the demand for chemotherapy induced peripheral neuropathy diagnoses and treatments.
Approfondimenti di mercato
L'aumento della prevalenza del cancro stimola la crescita del mercato della neuropatia periferica indotta dalla chemioterapiaNeuropathy Market Growth
Il cancro è una delle principali cause di morte in tutto il mondo. Secondo l'Organizzazione Mondiale della Sanità (OMS), il cancro è stato segnalato come la prima causa di morte nelle persone di età inferiore ai 70 anni in 183 paesi e la quarta causa di morte tra la popolazione di tutte le età in 123 paesi in tutto il mondo nel 2019. Inoltre, secondo i dati pubblicati dall'OMS a marzo 2021, diversi tipi di cancro hanno causato circa 10 milioni di decessi nel 2020.
Le forme di cancro più diffuse al mondo, 2020
- Questo campione GRATUITO includerà analisi di dati che spaziano dalle tendenze di mercato alle stime e alle previsioni.
La crescente prevalenza del cancro ha creato un peso sui sistemi sanitari in tutto il mondo, oltre ad aumentare la domanda di chemioterapia. La neuropatia periferica indotta dalla chemioterapia è un effetto avverso comune dei farmaci antitumorali neurotossici, come i farmaci derivati dal platino (cisplatino e oxaliplatino), i veleni del fuso [taxani (paclitaxel e docetaxel), alcaloidi della vinca, vincristina, epotiloni ed eribulina], bortezomib e talidomide. L'elevata prevalenza della neuropatia periferica indotta dalla chemioterapia solleva preoccupazioni sui pazienti oncologici e sui sopravvissuti, nonché sui loro operatori sanitari, soprattutto perché non esiste un unico modo efficace per prevenire questa condizione.neuropathy is a common adverse effect of neurotoxic anticancer drugs, such as platinum-derivative drugs (cisplatin and oxaliplatin), spindle poisons [taxanes (paclitaxel and docetaxel), vinca alkaloids, vincristine, epothilones, and eribulin], bortezomib, and thalidomide. The high prevalence of chemotherapy-induced peripheral neuropathy raises concerns about cancer patients and survivors, and their healthcare providers, especially because there is no single effective way to prevent this condition.
In uno studio condotto da "The Journal of the International Association for the Study of Pain", la prevalenza della neuropatia periferica indotta da chemioterapia è stata segnalata al 68,1% (57,7-78,4) se misurata nel primo mese dopo la chemioterapia, al 60,0% (36,4-81,6) nel terzo mese e al 30,0% (6,4-53,5) nel sesto mese o successivamente. Pertanto, la crescente incidenza della neuropatia periferica indotta da chemioterapia con la crescente prevalenza del cancro stimola la crescita del mercato della neuropatia periferica indotta da chemioterapia.neuropathy prevalence was reported at 68.1% (57.7–78.4 when measured in the first month after chemotherapy, 60.0% (36.4–81.6) in the third month, and 30.0% (6.4–53.5) in the sixth month or later. Thus, the growing incidence of chemotherapy-induced peripheral neuropathy with the increasing prevalence of cancer boosts the growth of the chemotherapy-induced peripheral neuropathy market.
Approfondimenti basati sulla classe di farmaci
In base alla classe di farmaci, il mercato della neuropatia periferica indotta dalla chemioterapia è segmentato in steroidi, antidepressivi, anticonvulsivanti e narcotici. Nel 2021, il segmento degli steroidi ha detenuto la quota maggiore del mercato. Si prevede che il segmento degli anticonvulsivanti registrerà il CAGR più rapido del 6,2% durante il periodo di previsione. neuropathy market is segmented into steroids, antidepressants, anti-seizure, and narcotics. In 2021, the steroids segment held the largest share of the market. The anti-seizure segment is expected to register the fastest CAGR of 6.2% during the forecast period.
Informazioni basate sui canali di distribuzione
In base al canale di distribuzione, il mercato della neuropatia periferica indotta dalla chemioterapia è segmentato in farmacia ospedaliera, farmacia al dettaglio e farmacia online. Nel 2021, il segmento della farmacia ospedaliera ha detenuto la quota maggiore del mercato. Inoltre, si prevede che il segmento della farmacia al dettaglio riporterà il CAGR più elevato del 5,9% nel periodo 2021-2028.neuropathy market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. In 2021, the hospital pharmacy segment held the largest share of the market. Further, the retail pharmacy segment is expected to report the highest CAGR of 5.9% during 2021–2028.
Gli operatori del mercato della neuropatia periferica indotta dalla chemioterapia (CIPN) si concentrano sull'adozione di strategie organiche, come il lancio e l'espansione dei prodotti, per espandere la propria presenza e il portafoglio prodotti in tutto il mondo, nonché per soddisfare la crescente domanda.neuropathy (CIPN) market players focus on adopting organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide, as well as to meet the growing demands.
Ambito del rapporto di mercato sulla neuropatia periferica indotta dalla chemioterapiaNeuropathy Market Report Scope
Per Geografia
In base all'area geografica, il mercato della neuropatia periferica indotta dalla chemioterapia è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Regno Unito, Germania, Francia, Italia, Spagna e resto d'Europa), Asia Pacifico (Cina, Giappone, India, Australia, Corea del Sud e resto dell'Asia Pacifico), Medio Oriente e Africa (Emirati Arabi Uniti, Arabia Saudita, Sud Africa e resto del Medio Oriente e dell'Africa) e Sud e Centro America (Brasile, Argentina e resto del Sud e Centro America).
Profili aziendali
- Regenacy Pharmaceuticals, Inc.
- Asahi Kasei Pharma Corporation
- Novaremed
- Makscientific, LLC
- Azienda farmaceutica Wex Inc.
- Azienda farmaceutica Sova, Inc.
- Kineta, Inc.
- Società anonima
- Azienda farmaceutica Apexian, Inc.
- Società a responsabilità limitata
Ambito del rapporto sulla neuropatia periferica indotta da chemioterapia
| Attributo del report | Dettagli |
|---|---|
| Dimensioni del mercato nel 2021 | 813,48 milioni di dollari USA |
| Dimensioni del mercato entro il 2028 | 1.174,26 milioni di dollari USA |
| CAGR globale (2021 - 2028) | 5,4% |
| Dati storici | 2019-2020 |
| Periodo di previsione | 2022-2028 |
| Segmenti coperti | Per classe di farmaci
|
| Regioni e Paesi coperti | America del Nord
|
| Leader di mercato e profili aziendali chiave |
|
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The chemotherapy induced peripheral neuropathy market majorly consists of the players such as Regenacy Pharmaceuticals, Inc, Asahi Kasei Pharma Corporation., Novaremed, Makscientific, Llc, Wex Pharmaceuticals Inc., Sova Pharmaceuticals, Inc., Kineta, Inc., Aptinyx Inc., Apexian Pharmaceuticals, Inc., and Winsantor, Inc. amongst others.
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes of varying intensity and duration. Due to its high prevalence among cancer patients, CIPN constitutes a major problem for both cancer patients and survivors as well as for their health care providers, especially because, at the moment, there is no single effective method of preventing CIPN; moreover, the possibilities of treating this syndrome are very limited.
The chemotherapy induced peripheral neuropathy market, by drug class, is bifurcated into steroids, antidepressants, anti-seizure medicines, and narcotics. In 2021, the steroids segment held the largest share of the market. The anti-seizure medicines segment of the chemotherapy induced peripheral neuropathy market is expected to witness growth in its demand at the fastest CAGR during the forecast period.
The factors that are driving and restraining factors that will affect the chemotherapy induced peripheral neuropathy market in the coming years. Major factors driving the market growth include the increasing prevalence of cancer and increasing preference for chemotherapy. Additionally, the growing clinical trials for chemotherapeutic drugs is likely to emerge as a significant future trend in the market during the forecast period. However, lack of consolidated guidelines for chemotherapy hamper the chemotherapy induced peripheral neuropathy market growth.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Chemotherapy Induced Peripheral Neuropathy Market
- REGENACY PHARMACEUTICALS, INC
- ASAHI KASEI PHARMA CORPORATION
- NOVAREMED
- MAKSCIENTIFIC, LLC
- WEX PHARMACEUTICALS INC
- SOVA PHARMACEUTICALS, INC
- KINETA, INC.
- APTINYX INC.
- APEXIAN PHARMACEUTICALS, INC.
- WINSANTOR, INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For